
Posts
Rate Of ReturnOnce again proving that non-US companies are not to be touched, and the right way is to honestly follow Trump. Look at Eli Lilly, and then look at this Novo Nordisk, the facts will rub people on the ground.
The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
